Antitrust & Trade Regulation Report Index-Summary

GAMBLING

– Horse racing, track owners may pursue boycott claims against horsemen (W.D. Ky.), 96:321
– La., riverboat casinos, Noerr-Pennington doctrine does not immunize bribery to secure gambling licenses (La.), 96:567

GAS

See OIL AND GAS

GENERIC DRUGS

– AndroGel, firms cited for illegal collusion in delayed introduction of generics (C.D. Cal.), 96:110
– Antidepressants, various indirect purchaser claims dismissed for lack of standing under state laws (E.D. Pa.), 97:179
– Arthritis, citizen petition from patent holder re bioequivalence studies was not sham (S.D.N.Y.), 97:263
– Authorized generics

– – Blood thinners, BMS to pay civil fine for secret oral agreement to delay introduction of authorized generic (D.D.C.), 96:318; executive pleads guilty to misleading government, 96:353
– – Competitive impact of authorized generics, FTC releases report, 96:641
– – Complete list, senators urge FDA to publish, 96:157
– – Prohibition on brand-name drug companies from offering

See LEGISLATION, FEDERAL, HR 573, S 369, S 501

– Delayed market entry, bill to prohibit

See LEGISLATION, FEDERAL, HR 1706, S 369

– Diabetes drug, direct purchasers have standing to assert monopoly claims (2d Cir.), 97:445
– Epilepsy, company must defend claims of patent manipulation to prevent generic competition (D.N.J.), 97:260
– EU, company practices delayed entry of generics, report finds, 97:70; investigation launched, 97:71
– Follow-on biologics, grant of FDA authority to approve would reduce costs of biotech drugs, FTC report says, 96:586
– Patent fraud claim may proceed, restraint of trade claims fail (9th Cir.), 96:37
– Reverse payments not per se unlawful during exclusionary zone of patent (U.S., rev den), 96:640; DOJ amicus brief argues illegality of payments (2d Cir.), 97:37
– Testosterone replacement, firms cited for illegal collusion in abandoned patent challenges (C.D. Cal.), 96:110; monopoly claim challenging patent settlement transferred, 96:372

GERMANY

– Auto industry, state aid draws EU statement, 97:307
– Cement, bundled damage claims may proceed, 96:491
– Gas, EC accepts divestitures by firm accused of dominance, 96:281
– Mergers and acquisitions, restrictions on combinations eased, 96:194
– Personal care products, price fixing scheme had no effect on U.S. market, subject matter jurisdiction lacking (N.D. Ill), 96:23

GREECE

– Lignite deposits, fair access measures accepted by EU, 97:156

GROCERY STORES

– South Africa, Competition Commission launches probe, 97:127
– UK, Julian Graves/Holland & Barrett merger referred to Competition Commission, 96:305
– Whole Foods/Wild Oats merger, court to weigh equities for enjoining (D.D.C.), 96:41; data sought from rival markets to prove competition, 96:42; request to delay trials in 29 jurisdictions rejected (D.C. Cir.), 96:85; settlement reached, divestitures required , 96:237
– Wholesale suppliers, lack of ties to Wisconsin leads to Minnesota transfer (W.D. Wis.), 96:509